171 related articles for article (PubMed ID: 33070895)
1. Prothrombin complex concentrate for vitamin K antagonist reversal in traumatic intracranial hemorrhage.
Beynon C; Nofal M; Rizos T; Laible M; Sakowitz OW; Unterberg AW
J Clin Neurosci; 2020 Sep; 79():197-202. PubMed ID: 33070895
[TBL] [Abstract][Full Text] [Related]
2. Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Bleeding in Neurosurgical Patients: A Single-Center Experience.
Mačiukaitienė J; Bilskienė D; Tamašauskas A; Bunevičius A
Medicina (Kaunas); 2018 Apr; 54(2):. PubMed ID: 30344253
[No Abstract] [Full Text] [Related]
3. Low-dose Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Hemorrhage with INR Less Than 2.0.
Zemrak WR; Smith KE; Rolfe SS; May T; Trowbridge RL; Hayes TL; Grindlinger GA; Seder DB
Neurocrit Care; 2017 Dec; 27(3):334-340. PubMed ID: 28660341
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation Reversal with Prothrombin Complex Concentrate in Aneurysmal Subarachnoid Hemorrhage.
Beynon C; Nofal M; Rizos T; Laible M; Potzy A; Unterberg AW; Sakowitz OW
J Emerg Med; 2015 Nov; 49(5):778-84. PubMed ID: 26234714
[TBL] [Abstract][Full Text] [Related]
5. Combination Therapy Using Prothrombin Complex Concentrate and Vitamin K in Anticoagulated Patients with Traumatic Intracranial Hemorrhage Prevents Progressive Hemorrhagic Injury: A Historically Controlled Study.
Koyama H; Yagi K; Hara K; Matsubara S; Tao Y; Uno M
Neurol Med Chir (Tokyo); 2021 Jan; 61(1):47-54. PubMed ID: 33208582
[TBL] [Abstract][Full Text] [Related]
6. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
[TBL] [Abstract][Full Text] [Related]
7. Inactivated Four-Factor Prothrombin Complex Concentrate Dosing Practices for Reversal of Warfarin-Related Intracranial Hemorrhage.
Rhoney DH; La M; Merz M; Cook A; Owusu KA; Roels C; Blunck J; Shewmaker J; Sangha KS; Farrokh S; Lewin J; Chester KW; Human T; Bledsoe K; Greene K; Levesque M; Rocker JC; Davis G; Neyens R; Lassiter TF; Adriance SM
Neurocrit Care; 2021 Aug; 35(1):130-138. PubMed ID: 33219462
[TBL] [Abstract][Full Text] [Related]
8. Impact of timing and dosing of four-factor prothrombin complex concentrate administration on outcomes in warfarin-associated intracranial hemorrhage.
Cicci CD; Weiss A; Dang C; Stanton M; Feldman R
Pharmacotherapy; 2022 May; 42(5):366-374. PubMed ID: 35384000
[TBL] [Abstract][Full Text] [Related]
9. Activated prothrombin complex concentrate for warfarin reversal in traumatic intracranial hemorrhage.
Carothers C; Giancarelli A; Ibrahim J; Hobbs B
J Surg Res; 2018 Mar; 223():183-187. PubMed ID: 29433872
[TBL] [Abstract][Full Text] [Related]
10. Administration of 4-Factor Prothrombin Complex Concentrate as an Antidote for Intracranial Bleeding in Patients Taking Direct Factor Xa Inhibitors.
Grandhi R; Newman WC; Zhang X; Harrison G; Moran C; Okonkwo DO; Ducruet AF
World Neurosurg; 2015 Dec; 84(6):1956-61. PubMed ID: 26341438
[TBL] [Abstract][Full Text] [Related]
11. Three-Factor Versus Four-Factor Prothrombin Complex Concentrate for the Emergent Management of Warfarin-Associated Intracranial Hemorrhage.
Fischer D; Sorensen J; Fontaine GV
Neurocrit Care; 2018 Feb; 28(1):43-50. PubMed ID: 28612131
[TBL] [Abstract][Full Text] [Related]
12. Prothrombin Complex Concentrate for Emergent Reversal of Intracranial Hemorrhage in Patients with Ventricular Assist Devices.
Lai GY; Maas MB; Leong CR; Liotta EM; Rich JD; Pham DT; Vorovich EE; Naidech AM; Jahromi BS; Potts MB
Neurocrit Care; 2021 Oct; 35(2):506-517. PubMed ID: 33821403
[TBL] [Abstract][Full Text] [Related]
13. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
Le Roux P; Pollack CV; Milan M; Schaefer A
J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
[TBL] [Abstract][Full Text] [Related]
14. Impact of Factor Xa Inhibitor Reversal with Prothrombin Complex Concentrate in Patients with Traumatic Brain Injuries.
Cooksey GE; Hamilton LA; McMillen JC; Griffard JH; Rowe AS
Neurocrit Care; 2022 Oct; 37(2):471-478. PubMed ID: 35624388
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Warfarin Reversal with 4-Factor Prothrombin Complex Concentrate Compared to 3-Factor Prothrombin Complex Concentrate at a Tertiary Academic Medical Center.
Al-Majzoub O; Rybak E; Reardon DP; Krause P; Connors JM
J Emerg Med; 2016 Jan; 50(1):7-13. PubMed ID: 26433428
[TBL] [Abstract][Full Text] [Related]
16. Impact of a Pharmacist-Driven Prothrombin Complex Concentrate Protocol on Time to Administration in Patients with Warfarin-associated Intracranial Hemorrhage.
Corio JL; Sin JH; Hayes BD; Goldstein JN; Fuh L
West J Emerg Med; 2018 Sep; 19(5):849-854. PubMed ID: 30202498
[TBL] [Abstract][Full Text] [Related]
17. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
Yasaka M; Sakata T; Naritomi H; Minematsu K
Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
[TBL] [Abstract][Full Text] [Related]
18. Fixed Versus Variable Dosing of Prothrombin Complex Concentrate in Vitamin K Antagonist-Related Intracranial Hemorrhage: A Retrospective Analysis.
Abdoellakhan RA; Miah IP; Khorsand N; Meijer K; Jellema K
Neurocrit Care; 2017 Feb; 26(1):64-69. PubMed ID: 27052728
[TBL] [Abstract][Full Text] [Related]
19. Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice.
Desmettre T; Dehours E; Samama CM; Jhundoo S; Pujeau F; Guillaudin C; Hecquart C; Clerson P; Crave JC; Jaussaud R
Crit Care; 2012 Oct; 16(5):R185. PubMed ID: 23036234
[TBL] [Abstract][Full Text] [Related]
20. Adverse Events Following International Normalized Ratio Reversal in Intracerebral Hemorrhage.
Laible M; Jenetzky E; Beynon C; Müller OJ; Sander P; Schüler S; Purrucker J; Möhlenbruch M; Steiner T; Veltkamp R; Ringleb PA; Rizos T
Cerebrovasc Dis; 2016; 42(5-6):446-454. PubMed ID: 27536779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
